Journal of the American Academy of Child & Adolescent Psychiatry
ARTICLESSleep-Related Problems Among Children and Adolescents With Anxiety Disorders
Section snippets
Participants
Participants were 128 children, 6 to 17 years of age (mean, 10.8 years), who met DSM-IV criteria for GAD, SAD, and/or SOC on the basis of child and parent Schedule for Affective Disorders and Schizophrenia for School-Aged Children (Kaufman et al., 1997) interviews with a trained clinician (see Research Units on Pediatric Psychopharmacology Anxiety Study Group, 2001). All children were enrolled in a double-blind, placebo-controlled, clinical trial of FLV for youth with anxiety disorders (i.e.,
Gender, Age, and Anxiety Disorder
Frequencies of the eight sleep items are presented in Tables 2 and 3 for the total sample and by gender, age group, and diagnosis (GAD, SAD, and SOC). Eighty-eight percent of the total sample reported at least one SRP; 55% reported three or more SRPs. The most common SRPs were insomnia, nightmares, and refusal/reluctance to sleep alone.
Prevalence of SRPs Among Anxious Youth
Eighty-eight percent of anxious youth experienced at least one SRP, and more than half experienced three or more. The most common SRPs were insomnia, nightmares, and reluctance/refusal to sleep alone. Rates of insomnia found in the present study are consistent with data indicating insomnia to be present among 60% to 70% of adults with anxiety disorders (Ohayon, 1997, Uhde, 2000). Although there were no gender or age differences in total number of SRPs, nightmares were significantly more common
REFERENCES (31)
- et al.
Sleep disturbances and teacher ratings of school achievement and temperament in children
Sleep Med
(2006) - et al.
Anxiety disorders in children: family matters
Cog Behav Pract
(2004) - et al.
Sleep problems in childhood: a longitudinal study of developmental change and association with behavioral problems
J Am Acad Child Adolesc Psychiatry
(2002) - et al.
Schedule for affective disorders and schizophrenia for school-aged children-present and lifetime version (K-SADS-PL): initial reliability and validity
J Am Acad Child Adolesc Psychiatry
(1997) - et al.
On the physiological symptom constellation in youth with generalized anxiety disorder (GAD)
J Anxiety Disord
(2003) - et al.
The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders
J Affect Disord
(1988) - et al.
Generalized anxiety disorder in referred children and adolescents
J Am Acad Child Adolesc Psychiatry
(2004) - et al.
Developmental features of sleep
Child Adol Psychiatr Clin N Am
(1999) - et al.
Sleep disturbance in generalized anxiety disorder and its treatment
Sleep Med Rev
(2000) Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders
J Psychiatr Res
(1997)
Sleep patterns in depression and anxiety: theory and pharmacological effects
J Psychosom Res
Maternal panic disorder: infant temperament, neurophysiology, and parenting behaviors
J Am Acad Child Adolesc Psychiatry
Manual for the Child Behavior Checklist
Family process and child anxiety and aggression: an observational analysis
J Abnorm Child Psychol
The regulation of sleep and arousal: development and psychopathology
Dev Psychopathol
Cited by (274)
Difficulties in emotion regulation moderates the relationship between mood symptoms and nightmares in an inpatient psychiatric sample
2024, Journal of Affective DisordersThe associations among sleep-related difficulties, anxiety, and error-related brain activity in youth
2024, Biological PsychologySocial interaction anxiety and sleep quality in youth: Individual difference in childhood adversity and cardiac vagal control
2024, Journal of Affective DisordersSleep-Related Problems and Pediatric Anxiety Disorders
2024, Psychiatric Clinics of North AmericaClassification and Epidemiology of Sleep Disorders in Children and Adolescents
2024, Psychiatric Clinics of North America
Preparation of this paper was supported by NIMH grant K23-MH63427-02 awarded to Dr. Ginsburg.
The authors wish to acknowledge the Research Units on Pediatric Psychopharmacology Anxiety Group (RUPP) sites that supported the data collection for this study: Mark A. Riddle, M.D., John T. Walkup, M.D., and Michael J. Labellarte, M.D., Johns Hopkins University; Daniel S. Pine, M.D., Laurence Greenhill, M.D., Rachel Klein, Ph.D., and Michael Sweeney, Ph.D., Columbia University and New York State Psychiatric Institute; Howard Abikoff, Ph.D., Sabine Hack, M.D., and Brian Klee, M.D., New York University; James McCracken, M.D., Lindsey Bergman, Ph.D., and John Piacentini, Ph.D., University of California, Los Angeles; John March, M.D., M.P.H., and Scott Compton, Ph.D., Duke University; and Ben Vitiello, M.D., National Institute of Mental Health.
Disclosure: The authors have no financial relationships to disclose.
- 1
Dr. Alfano is with the Department of Psychiatry, Children's National Medical Center, Washington, DC; Drs. Ginsburg and Kingery are with the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine, Baltimore.